Shulman Joseph
SEC CIK 1909855 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Chief Technical Off | 21.0K | — | $15.75M | 53 | 2022-02-11 | 2026-08-13 |
Most active insiders at RYTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Jennifer Kayden | EVP, Head of North America | — | $8.90M |
| 2 | Smith Hunter C | CFO | — | $8.84M |
| 3 | Mazabraud Yann | EVP, Head of International | — | $6.62M |
| 4 | Meeker David P | Pres, CEO, Dir | — | $5.13M |
| 5 | TETRAULT LYNN A. | Dir | — | $3.71M |
| 6 | Shulman Joseph | Chief Technical Off | — | $3.67M |
| 7 | Cramer Pamela J. | CHRO | — | $2.99M |
| 8 | German Christopher Paul | CAO, Corp. Ctrl | — | $930.9K |
| 9 | Garfield Alastair | CSO | — | $912.7K |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 53
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-17 18:00 | 2026-08-13 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $6.80 | +2,024 | 21.0K | +11% | +$13.8K |
| DT | 2026-08-17 18:00 | 2026-08-13 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $119.75 | -5,079 | 15.9K | -24% | -$608.2K |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | F - Tax | $108.99 | -6,507 | 19.0K | -26% | -$709.2K |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | — | +17.0K | 25.5K | +199% | — |
| D | 2025-11-03 | 2025-10-30 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $30.66 | +9,748 | 18.3K | +115% | +$298.9K |
| D | 2025-11-03 | 2025-10-30 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $115.24 | -9,748 | 8,509 | -53% | -$1.12M |
| DM | 2025-10-30 | 2025-10-28 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $28.20 | +2,815 | 11.3K | +33% | +$79.4K |
| D | 2025-10-30 | 2025-10-28 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $115.01 | -2,815 | 8,509 | -25% | -$323.8K |
| DM | 2025-10-20 | 2025-10-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $30.18 | +14.4K | 10.6K | New | +$435.7K |
| DM | 2025-10-20 | 2025-10-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $112.03 | -14.4K | 20.3K | -42% | -$1.62M |
| DM | 2025-09-04 | 2025-09-02 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $30.25 | +16.8K | 10.6K | New | +$507.6K |
| D | 2025-09-04 | 2025-09-02 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $105.30 | -16.8K | 8,509 | -66% | -$1.77M |
| D | 2025-08-25 | 2025-08-21 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $100.07 | -4,188 | 8,509 | -33% | -$419.1K |
| D | 2025-08-25 | 2025-08-21 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $27.35 | +4,188 | 12.7K | +49% | +$114.5K |
| D | 2025-08-13 | 2025-08-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $90.08 | -3,984 | 8,509 | -32% | -$358.9K |
| D | 2025-08-13 | 2025-08-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $6.80 | +3,984 | 12.5K | +47% | +$27.1K |
| D | 2025-07-11 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $6.80 | +7,969 | 16.5K | +94% | +$54.2K |
| DM | 2025-07-11 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $77.78 | -7,969 | 8,509 | -48% | -$619.8K |
| D | 2025-02-19 | 2025-02-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $57.22 | -1,228 | 8,509 | -13% | -$70.3K |
| D | 2025-02-19 | 2025-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | — | +4,125 | 9,737 | +74% | — |
| M | 2025-02-14 | 2025-02-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale | $56.40 | -469 | 5,612 | -8% | -$26.5K |
| DM | 2025-02-11 | 2025-02-09+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | — | +4,218 | 6,875 | +159% | — |
| DM | 2025-02-11 | 2025-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $57.51 | -794 | 6,084 | -12% | -$45.7K |
| D | 2025-02-04 | 2025-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | — | +3,938 | 3,938 | New | — |
| D | 2025-02-04 | 2025-02-04 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $59.43 | -1,281 | 2,657 | -33% | -$76.1K |
| DMA | 2024-11-13 | 2024-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $20.54 | +69.2K | 70.4K | +5,511% | +$1.42M |
| DM | 2024-11-13 | 2024-11-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $66.43 | -13.3K | 0 | -100% | -$882.3K |
| DM | 2024-11-13 | 2024-11-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $12.63 | +13.3K | 7,969 | New | +$167.8K |
| D | 2024-07-18 | 2024-07-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $53.00 | -10.5K | 30 | -100% | -$554.8K |
| D | 2024-07-18 | 2024-07-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $27.35 | +10.5K | 10.5K | +34,893% | +$286.3K |
| D | 2024-07-16 | 2024-07-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $50.01 | -5,313 | 30 | -99% | -$265.7K |
| D | 2024-07-16 | 2024-07-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $21.38 | +5,313 | 5,343 | +17,710% | +$113.6K |
| DM | 2024-05-13 | 2024-05-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $38.47 | -3,984 | 530 | -88% | -$153.3K |
| D | 2024-05-13 | 2024-05-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $6.80 | +3,984 | 4,014 | +13,280% | +$27.1K |
| 2024-03-22 | 2024-03-21 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale | $40.34 | -18.2K | 30 | -100% | -$735.6K | |
| 2024-03-19 | 2024-03-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale | $39.22 | -15.5K | 18.3K | -46% | -$608.5K | |
| D | 2024-02-21 | 2024-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | A - Grant | $0.00 | +33.8K | 33.8K | +112,500% | $0 |
| M | 2024-02-15 | 2024-02-13+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale | $50.00 | -2,954 | 1,119 | -73% | -$147.7K |
| DM | 2024-02-13 | 2024-02-09+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $50.39 | -73.0K | 74.4K | -50% | -$3.68M |
| DM | 2024-02-13 | 2024-02-09+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $21.38 | +73.4K | 74.5K | +6,978% | +$1.57M |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | — | +3,938 | 3,938 | New | — |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $45.06 | -1,324 | 2,614 | -34% | -$59.7K |
| DM | 2023-12-29 | 2023-12-27+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $50.00 | -12.9K | 1,126 | -92% | -$647.1K |
| DM | 2023-12-29 | 2023-12-27+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $21.38 | +9,200 | 7,926 | New | +$196.7K |
| D | 2023-11-16 | 2023-11-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | $6.80 | +27.9K | 31.6K | +746% | +$189.7K |
| D | 2023-11-16 | 2023-11-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $32.07 | -27.9K | 3,741 | -88% | -$894.4K |
| A | 2023-02-14 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale | $27.51 | -931 | 2,732 | -25% | -$25.6K |
| D | 2023-02-14 | 2023-02-14 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $26.87 | -554 | 3,741 | -13% | -$14.9K |
| D | 2023-02-14 | 2023-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | — | +1,563 | 4,295 | +57% | — |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | — | +2,657 | 3,663 | +264% | — |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $27.66 | -921 | 2,742 | -25% | -$25.5K |
| D | 2022-02-15 | 2022-02-15 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | S - Sale+OE | $6.10 | -557 | 1,006 | -36% | -$3,398 |
| D | 2022-02-15 | 2022-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Off | M - OptEx | — | +1,563 | 1,563 | New | — |
Purchase Sale Sale after option exercise All abbreviations